QUantitative Flow Ratio Or Angiography for the assessMent of nOn-culprit Lesions
QUOMODO
1 other identifier
interventional
200
1 country
1
Brief Summary
The aim of this study is to study whether the use of complex 3-dimensional assessment of the severity of a stenosis improves angina and in general cardiovascular outcomes in patients who have residual intermediate coronary artery stenosis following an acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI). Goals of the study are:
- To investigate whether decision-making based on quantitative flow reserve (QFR) is associated with a decrease in angina 3 months after an ACS
- To investigate whether use of QFR is associated with an improved prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 coronary-artery-disease
Started Oct 2020
Typical duration for phase_4 coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
March 17, 2021
CompletedFirst Posted
Study publicly available on registry
March 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2024
CompletedOctober 8, 2024
October 1, 2024
2.5 years
March 17, 2021
October 6, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Patient-oriented combined endpoint (clinical endpoint)
composite of patient-oriented events and significant angina (all-cause death, non fatal myocardial infarction including type 1, 2, 4, unplanned hospitalization for angina or heart failure, unplanned revascularization, SAQ\<90)
12 months
Functional endpoint
Proportion of patients assigned to medical treatment in the two groups (QFR vs. Reference)
Upon randomization and following QFR assessment
Secondary Outcomes (5)
Seattle angina questionaire summary score
12 months
Seattle angina questionaire summary score
3 months
Unplanned admission
12 months
Patient-oriented composite endpoint
3 months
Patient-oriented composite endpoint
12 months
Study Arms (2)
Angiography
ACTIVE COMPARATORThe indication to further coronary intervention will be based on angiographic diameter stenosis.
Quantitative flow ratio (QFR)
EXPERIMENTALThe indication to further coronary intervention will be based on QFR.
Interventions
Quantitative flow ratio (QFR) is a computer method that estimates the hemodynamic relevance of a coronary stenosis based on three-dimensional quantitative coronary angiography (3D QCA)
The indication to coronary stent intervention will be based on angiography
Eligibility Criteria
You may qualify if:
- Successfully treated acute coronary syndrome
- At least one additional intermediate stenosis (\>30% and \<90%).
- Patient ≥18 years old
You may not qualify if:
- Stenoses or patients a priori not amenable to treatment with PCI (at the discretion of two interventional cardiologists - e.g. patients with limited life expectancy, stenosis in very small vessels, very diffuse disease with complex/very calcified stenosis requiring surgery etc).
- Persistent symptoms or evidence of ischemia requiring intervention of the non-culprit lesion.
- Any contraindication to PCI according to guidelines
- An ACS in the period following the index ACS and randomization
- TIMI (Thrombolysis in Myocardial Infarction) flow grade \< 3 in the culprit vessel
- Presence of thrombus in the non-culprit lesion
- Participation in another randomized interventional study interfering with the present protocol
- Patient unable to give informed consent
- Women of child-bearing potential or lactating
- Previous coronary artery bypass surgery CABG
- Recent (within 30 days) unsuccessful PCI
- Decompensated congestive heart failure (CHF) or hospitalization due to CHF during the last 3 months
- Left ventricular ejection fraction \<30%
- Severe chronic obstructive pulmonary disease (COPD)
- Severe valvular heart disease
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center of Cardiology, Cardiology I, university hospital Mainz
Mainz, Rhineland-Palatinate, 55131, Germany
Related Publications (2)
Ullrich-Daub H, Olschewski M, Schnorbus B, Belhadj KA, Kohler T, Vosseler M, Munzel T, Gori T. Quantitative flow ratio or angiography for the assessment of non-culprit lesions in acute coronary syndromes, a randomized trial. Clin Res Cardiol. 2025 Jun;114(6):729-737. doi: 10.1007/s00392-024-02484-5. Epub 2024 Jul 9.
PMID: 38980329DERIVEDUllrich H, Olschewski M, Belhadj KA, Munzel T, Gori T. Quantitative Flow Ratio or Angiography for the Assessment of Non-culprit Lesions in Acute Coronary Syndromes: Protocol of the Randomized Trial QUOMODO. Front Cardiovasc Med. 2022 Apr 4;9:815434. doi: 10.3389/fcvm.2022.815434. eCollection 2022.
PMID: 35445090DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Patients and outcome assessors will be blinded to the randomization group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
March 17, 2021
First Posted
March 22, 2021
Study Start
October 1, 2020
Primary Completion
April 1, 2023
Study Completion
April 17, 2024
Last Updated
October 8, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share